BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36991316)

  • 41. Testicular yolk sac tumor of myxomatous, reticular, and polyvesicular vitelline type in a newborn calf.
    Sakaguchi K; Matsuda K; Suzuki H; Yamamoto N; Kondo Y; Ando T; Koiwa M; Kagawa Y; Taniyama H
    J Vet Diagn Invest; 2013 Nov; 25(6):811-5. PubMed ID: 24153035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group.
    Williams LA; Mills L; Hooten AJ; Langer E; Roesler M; Frazier AL; Krailo M; Nelson HH; Bestrashniy J; Amatruda JF; Poynter JN
    Br J Cancer; 2018 Oct; 119(7):864-872. PubMed ID: 30287918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occurrence of metachronous pure germinomas long after treatment of a mixed germ cell tumor containing yolk sac tumor and germinoma.
    Jinguji S; Okamoto K; Yoshimura J; Yoneoka Y; Ogura R; Saito A; Fujii Y
    J Neurosurg Pediatr; 2013 Jan; 11(1):68-73. PubMed ID: 23082803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human germ cell tumours: expression of gamma-glutamyl transpeptidase and sensitivity to cisplatin.
    Hanigan MH; Frierson HF; Abeler VM; Kaern J; Taylor PT
    Br J Cancer; 1999 Sep; 81(1):75-9. PubMed ID: 10487615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sacrococcygeal yolk sac tumor developing after teratoma: a clinicopathological study of pediatric sacrococcygeal germ cell tumors and a proposal of the pathogenesis of sacrococcygeal yolk sac tumors.
    Yoshida M; Matsuoka K; Nakazawa A; Yoshida M; Inoue T; Kishimoto H; Nakayama M; Takaba E; Hamazaki M; Yokoyama S; Horie H; Tanaka M; Gomi K; Ohama Y; Kigasawa H; Kitano Y; Uchida H; Kanamori Y; Iwanaka T; Tanaka Y
    J Pediatr Surg; 2013 Apr; 48(4):776-81. PubMed ID: 23583133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mixed Germ Cell Tumor with a Yolk Sac Tumor Component in the Medulla Oblongata of a 50-year-old Patient: A Case Report and Literature Review.
    Isaji T; Iwami K; Ato F; Watanabe T; Takahashi E; Miyachi S
    Intern Med; 2023 Mar; 62(6):915-921. PubMed ID: 35989277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synchronous solitary calvarial yolk sac tumor metastasis as the initial presentation of mediastinal germ cell tumor.
    Gupta K; Karthigeyan M; Satapathy A; Salunke P
    Childs Nerv Syst; 2018 Feb; 34(2):363-366. PubMed ID: 29032518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
    Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
    Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian yolk sac tumour in a girl - case report.
    Sharma C; Shah H; Sisodiya Shenoy N; Makhija D; Waghmare M
    Dev Period Med; 2017; 21(2):101-103. PubMed ID: 28796980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
    Kohmoto T; Masuda K; Shoda K; Takahashi R; Ujiro S; Tange S; Ichikawa D; Otsuji E; Imoto I
    Gastric Cancer; 2020 May; 23(3):403-417. PubMed ID: 31654186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical characteristics and prognostic factors of male yolk sac tumor: a Surveillance, Epidemiology, and End Results program study.
    Geng R; Zheng Z; Lin Y; Li Y; Ge G; Zhang J; Wang C; Dai X; Ye Q; Zhen J; Zhang Y; Fu C; Li Y
    World J Urol; 2021 Apr; 39(4):1211-1217. PubMed ID: 32562046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary orbital yolk sac tumor: report of a case and review of literature.
    Kamal S; Kaliki S; Sreedhar A; Mishra DK
    Int Ophthalmol; 2016 Jun; 36(3):435-44. PubMed ID: 26481249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.
    Chen KS; Fustino NJ; Shukla AA; Stroup EK; Budhipramono A; Ateek C; Stuart SH; Yamaguchi K; Kapur P; Frazier AL; Lum L; Looijenga LHJ; Laetsch TW; Rakheja D; Amatruda JF
    Mol Cancer Ther; 2018 May; 17(5):1079-1089. PubMed ID: 29483210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of non-midline primary malignant germ cell tumors with yolk sac components in neonates: report of 2 cases.
    Weil AG; Mathews N; Farmer JP; St Martin C; Albrecht S; Jabado N; Dudley RWR
    J Neurosurg Pediatr; 2020 Oct; 27(1):47-51. PubMed ID: 33126205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brentuximab vedotin exerts profound antiproliferative and pro-apoptotic efficacy in CD30-positive as well as cocultured CD30-negative germ cell tumour cell lines.
    Schönberger S; van Beekum C; Götz B; Nettersheim D; Schorle H; Schneider DT; Casati A; Craveiro RB; Calaminus G; Dilloo D
    J Cell Mol Med; 2018 Jan; 22(1):568-575. PubMed ID: 28941150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pure post-pubertal yolk sac tumor of the testis: An extremely rare and aggressive entity.
    Patel S; Satturwar S; Khan W; Ashman D; Quiroga-Garza GM
    Ann Diagn Pathol; 2023 Apr; 63():152086. PubMed ID: 36580878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mucinous carcinoid as an unusual manifestation of endodermal differentiation in ovarian yolk sac tumors.
    Nogales FF; Buriticá C; Regauer S; González T
    Am J Surg Pathol; 2005 Sep; 29(9):1247-51. PubMed ID: 16096416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
    Simon AG; Lyu SI; Laible M; Wöll S; Türeci Ö; Şahin U; Alakus H; Fahrig L; Zander T; Buettner R; Bruns CJ; Schroeder W; Gebauer F; Quaas A
    J Transl Med; 2023 Aug; 21(1):552. PubMed ID: 37592303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EPCAM-A novel molecular target for the treatment of pediatric and adult germ cell tumors.
    Schönberger S; Okpanyi V; Calaminus G; Heikaus S; Leuschner I; Nicholson JC; Stoecklein NH; Schneider DT; Borkhardt A
    Genes Chromosomes Cancer; 2013 Jan; 52(1):24-32. PubMed ID: 22987628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
    Cao D; Guo S; Allan RW; Molberg KH; Peng Y
    Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.